(H2IPr)(Cl)2Ru=CH(o-iPrOC6H4)

Cat. No.: HY-W854275: Ficha de datos
SDS
Instrucciones de manejo
FAQs
Technical Support

(H2IPr)(Cl)2Ru=CH(o-iPrOC6H4) is a highly efficient catalyst that can effectively promote the metathesis reaction of olefins. The compound exhibits excellent selectivity in the field of transition metal catalysts, is suitable for the synthesis of biologically active compounds, and shows potential application value in compound development.

Para uso exclusivo en investigación. No vendemos a pacientes.

(H2IPr)(Cl)2Ru=CH(o-iPrOC6H4) Estructura química

No. CAS : 635679-24-2

Tamaño	Stock	Cantidad
25 mg	En stock	Estimated Time of Arrival: December 31
50 mg	En stock	Estimated Time of Arrival: December 31
100 mg	En stock	Estimated Time of Arrival: December 31
250 mg	En stock	Estimated Time of Arrival: December 31
500 mg	Obtener un presupuesto
1 g	Obtener un presupuesto

or Consulta para venta a granel

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Recomendaciones destacadas

•Related Small Molecules:

•Related Proteins:

Ver todos los productos específicos de isoformas Endogenous Metabolite:

Ver todas las isoformas

Human Endogenous Metabolite Microbial Metabolite

Actividad biológica
Pureza y Documentación
Referencias
Revisión del cliente

Descripciòn	(H2IPr)(Cl)2Ru=CH(o-iPrOC6H4) is a highly efficient catalyst that can effectively promote the metathesis reaction of olefins. The compound exhibits excellent selectivity in the field of transition metal catalysts, is suitable for the synthesis of biologically active compounds, and shows potential application value in compound development.
Peso molecular	710.78
Fòrmula	C₃₇H₅₀Cl₂N₂ORu
No. CAS	635679-24-2
Appearance	Solid
Color	Green to dark green
SMILES	[Cl-][Ru+6]1([Cl-])(=[CH-2]C2=C(O1C(C)C)C=CC=C2)=[C-2]3N(CCN3C4=C(C(C)C)C=CC=C4C(C)C)C5=C(C(C)C)C=CC=C5C(C)C
Envío	Room temperature in continental US; may vary elsewhere.
Almacenamiento	4°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
Pureza y Documentación	Ficha de datos (274 KB) SDS (252 KB) Instrucciones de manejo (2659 KB)
Referencias	[1]. A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD)Kalaitzakis E and Bjornsson ETherapeutics and Clinical Risk Management2007 [2]. Esomeprazole increases airway surface liquid pH in primary Cystic Fibrosis epithelial cells [3]. A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD)